What is SIGA Technologies, Inc. (SIGA)?

SIGA Technologies, Inc. (SIGA) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of SIGA?

The current price of SIGA is $3.04. Prices are updated in real time on Stocks360.

What is SIGA's price-to-earnings (PE) ratio?

SIGA's trailing twelve-month PE ratio is -69.72, based on current price and earnings per share data available on Stocks360.

What is SIGA's market capitalization?

SIGA's market capitalization is $218,423,088.00, placing it in the small-cap tier.

Does SIGA pay a dividend?

Yes. SIGA has a trailing twelve-month dividend yield of 0.20%. Dividend data is sourced from financial market providers and displayed on Stocks360.

SIGA Technologies, Inc. (SIGA)

Stock analysis · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

$3.04

Market Cap

$218.42M

PE (TTM)

-69.72

EPS (TTM)

N/A

Dividend Yield

19.74%

Beta

0.96

Day Range

$3.03 – $3.24

52-wk Range

$2.83 – $8.46

Avg Volume

N/A

Volume

504.05K

SIGA Technologies, Inc. (SIGA) is a publicly traded company in the Healthcare sector. Latest price: $3.04. Market cap $218.42M. Trailing PE -69.72. Dividend yield 19.74%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $8.28 2026-10-30 · $3.04 (-63.29%)

Earnings

Most Recent

May 1, 2014

EPS $-0.06 vs est. $0.22

Missed by $0.28

Next Earnings

Nov 9, 2026

EPS estimate $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About SIGA Technologies, Inc.

SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-69.72×
P/S (TTM)	4.07×
P/B	1.32×
PEG	0.67×
P/FCF (TTM)	-10.66×
EV / EBITDA	-20.66×
EV / Sales	1.89×
Earnings Yield	-1.26%
Free Cash Flow Yield	-9.38%
Dividend Yield	19.74%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$101.28M
Revenue (TTM)	$53.66M
Net Income (TTM)	-$2.76M
Free Cash Flow (TTM)	-$20.50M
Net Debt	-$117.15M
Working Capital	$162.53M
Gross Margin	54.35%
Operating Margin	-20.76%
Net Margin	-5.14%
Return on Equity	-1.53%
Return on Invested Capital	-3.33%